Skip to main content
Clinical Trials/NCT05122897
NCT05122897RecruitingNot Applicable

Temporary push-on Rings of Antimicrobial Alloys for Transmucosal Implant Abutment Systems: a Randomized Clinical Study on Early and Mature Biofilm Formation

University Hospital, Basel, Switzerland1 site in 1 country33 target enrollmentStarted: January 11, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
33
Locations
1
Primary Endpoint
Change in total bacterial load formed on the removable rings of each material

Study Overview

Brief Summary

This in-vivo study investigates early (48h), mature (2 weeks) and long-term (3 months) biofilm formation and composition on temporary push-on cones (exchangeable conical rings) made of noble-alloy-based materials (Pagalinor, PA) in comparison to Titanium-6Aluminum-7Niobium alloy (TAN) presently used in the transmucosal portion of dental implant abutments.

Detailed Description

Oral biofilm (dental plaque) consists of bacteria and their metabolic products as well as saliva components and food residues. It is recognizable as a tough and structured coating on teeth and artificial surfaces within the oral cavity. Plaque development is a physiological process that begins immediately after cleaning of the oral surface. If the biofilm is not removed by daily oral hygiene, it continues to mature while changing the structure and its microbial composition.

Implant restorations comprise the osseous implant portion predominantly manufactured from titanium alloys, the transmucosal implant portion (in most implant systems as a separate abutment), and the clinical crown, which is in most systems extraorally cemented on an abutment and screw-retained onto the implant. According to current knowledge, microbial colonization of the implant abutment surface plays a significant role in the aetiology of peri-implantitis.

This study investigates the antibacterial potential of a temporary push-on cone (conical ring) that could reduce the risk of bacterial related peri-implant diseases due to decreased biofilm susceptibility, compared to current available transmucosal materials, in the short- and long-run. The test material Pagalinor®2 (PA) is an established material in dental medicine and has proven to accumulate least biofilm in an in-vivo biofilm sampling model using removable splints. The control material consists of the current transmucosal implant abutment material Titanium-6Aluminum- 7Niobium alloy (TAN). The push-on rings are designed for repeated application along the transmucosal implant abutment portion with high precision fit and will allow biofilm sampling in the natural implant environment. Profound insight into the native homeostasis of biofilm formation will be obtained and therefore enhance the knowledge about long-term tissue response.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
Double (Participant, Investigator)

Masking Description

Double-blinded with the patient not knowing which material is placed, and the investigator and laboratory technicians have no information about the ring material.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Informed Consent signed by the subject
  • •Presence of one or more bone level titanium implant prior to insertion of the final restoration
  • •No systemic illness
  • •No heavy smoking (smoking <10 cigarettes/day)
  • •No pregnancy
  • •No active periodontitis (probing pocket depth ≤4 mm)
  • •No pharmacological treatment or antibiotic therapy during or up to three months before the study

Exclusion Criteria

  • •Systemic illness (e.g. Diabetes)
  • •Heavy smoking (smoking >10 cigarettes/day)
  • •Known or suspected non-compliance, drug or alcohol abuse
  • •Pregnancy
  • •Active periodontitis (probing pocket depth >4 mm)
  • •Pharmacological treatment or antibiotic therapy during or up to three months before the study

Arms & Interventions

Pagalinor®2 (PA) test arm

Experimental

All patients will wear both the test and control ring material for a within-subject comparison. Ideally, biofilm sampling can be performed in a split mouth design (randomly allocated materials within subjects) with one patient having two implants for placing the test and the control material at the same time. In addition, patients providing one implant, will receive test and control push-on rings in a randomly assigned order, so that both materials are assessed in a consecutive manner.

Intervention: Rings made of PA (test) (Device)

Titanium-6Aluminum- 7Niobium alloy (TAN) control arm

Active Comparator

All patients will wear both the test and control ring material for a within-subject comparison. Ideally, biofilm sampling can be performed in a split mouth design (randomly allocated materials within subjects) with one patient having two implants for placing the test and the control material at the same time. In addition, patients providing one implant, will receive test and control push-on rings in a randomly assigned order, so that both materials are assessed in a consecutive manner.

Intervention: Rings made of TAN (control) (Device)

Outcomes

Primary Outcomes

Change in total bacterial load formed on the removable rings of each material

Time Frame: at 48 hours after ring placement, 2 weeks after ring placement and 3 months after ring placement

Quantification of the bacterial load formed on the removable rings of each material by quantitative real-time PCR (qPCR) using primers specific to highly conserved regions of bacterial 16S rRNA genes.

Secondary Outcomes

  • Change in bleeding on probing (BoP)(at baseline, 2 weeks after ring placement and 10 weeks after ring placement)
  • Change in noninvasive laser doppler flowmetry(at baseline, 2 weeks after ring placement and 10 weeks after ring placement)
  • Change in the cells of the peri-implant soft tissue(at 2 weeks after ring placement)
  • Change in bacterial composition (taxonomic diversity) between different materials at various time points by using metagenomic sequencing analysis(at baseline, 2 weeks after ring placement and 10 weeks after ring placement)
  • Change in probing pocket depth (PPD) in mm(at baseline, 2 weeks after ring placement and 10 weeks after ring placement)

Investigators

Sponsor
University Hospital, Basel, Switzerland
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials